Skip to main content
Veterinary Medicines

RABISIN MULTI SUSPENSION INJECTABLE

Authorised
  • Rabies virus, strain G52, Inactivated

Product identification

Medicine name:
RABISIN MULTI SUSPENSION INJECTABLE
Active substance:
  • Rabies virus, strain G52, Inactivated
Target species:
  • Cattle
  • Ferret
  • Cat
  • Equid
  • Sheep
  • Dog
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Rabies virus, strain G52, Inactivated
    1.00
    international unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        0
        day
    • Equid
      • Meat and offal
        0
        day
    • Sheep
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Cattle
      • Meat and offal
        0
        day
    • Sheep
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AA02
Authorisation status:
  • Valid
Authorised in:
  • France
Available in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/0933976 5/2010
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 17/10/2025

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 17/10/2025